Comparative study of gatifloxacin and levofloxacin for urinary tract infection in 80 cases
Abstract
Objective:To evaluate the clinical efficacy and safety of gatifloxacin in the treatment of urinary tract infection.Methods:Eighty patients with urinary tract infection were randomly and equally divided to receive gatifloxacin(40 cases)or levofloxaoin(40 cases)at 0.4 g/d for 7d or 14d in both groups.Results:The total effective rate of gatifloxacin group and levofloxacin group was 97.5% and 82.5% respetively(P0.05),the bacterial clearance rate was 96.2% and 84.3%(P0.01)respectively.and the incidence of adverse reaction was 5% and 7.5%.respectively.Conclusion:Gatifloxacin is safe and effective for urinary tract infection.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.